Header widget area left
Header widget area right

Producing specified drug tablets with LISA

research own materials (drug/polymer powders) with open parameters
unlimited capacity to process any thermally stable drug substance
personalised dosage forms of pharmaceutical products

Background

The Centre for Innovation and Process Engineering Research (CIPER) has a worldwide reputation on the implementation of 3D printing technologies for the development of pharmaceutical dosage forms and medical devices. The Centre has attracted significant funding from industry and also EU Research Programs (e.g., INTERREG 2 Seas).

The Sinterit technology was used to optimize a wide range of pharmaceutical products in the form of tablets. The technology was coupled with Hot Melt Extrusion for the engineering of SLS printable powders. By using a wide range of polymers, they were able to print tablets with immediate, controlled and sustained release of drug products.

Problem

They were looking for a technology that can print extruded or granulated powders loaded with drug substances and that would not depend on the development of printable filaments. In addition, Sinterit technology helped to design and print tablets with complex geometries. More importantly it allowed the printing of several pharmaceutical grade polymers and produce tablets with drug amounts that was impossible to process with other techniques.

The technology gives unlimited capacity to process any thermally stable drug substance. Another important advantage is that allows them to accurately print tablet doses with different drug strength in the same batch and thus developed personalized dosage forms according to the need of the patients.

 

Solution

University of Greenwich bought Sinterit Solution in 2020 and they were able to print their designed structures within one month. The easy-to-use software is one of the major advantages of the technology. Also, the fact that they can control the powder amounts (very important for expensive drugs) and the processing parameters (e.g., environment temperature, bed temperature) makes the technology unique for their applications. The post processing equipment was very helpful to produce tablets without any unbound powder.

The technology is cost effective for the printing of pharmaceutical tablets as it reduces processing steps while it allows the printing of several tablets in batch-to-batch process. Sinterit can be used for the R&D but also printing of pharmaceutical products and more importantly for personalised dosage forms.

Visit our customer’s website: https://www.gre.ac.uk/

University of Greenwich
Customer:
Prof Dennis Douroumis, University of Greenwich
Country:
United Kingdom
Industry:
Education
Application:
Research, Prototyping (Pharmaceutical Dosage Forms)
Uses:
Enclosures, Containers
Top reasons:
Reactivity, Accuracy, Complexity, Simple Post Processing

research own materials (drug/polymer powders) with open parameters
unlimited capacity to process any thermally stable drug substance
personalised dosage forms of pharmaceutical products

Equipment used by University of Greenwich : Sinterit LISA 3D Printer
Powder Sieve
Material used: Own materials

    Subscribe to the newsletter

    And stay informed about new publications and videos


    Skip to content